project id: TCGA-KIRP; case submitter id: TCGA-F9-A8NY; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.11; rna integrity number: 9.3; age at index: 38; days to birth: -14101; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1975; age at diagnosis: 14101; ajcc clinical m: M1; ajcc clinical n: N1; ajcc clinical stage: Stage IV; ajcc clinical t: T4; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 36.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 112; days to sample procurement: 0; initial weight: 2430.0; portion submitter id: TCGA-F9-A8NY-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;